Literature DB >> 7621913

Receptors for adrenomedullin in human vascular endothelial cells.

J Kato1, K Kitamura, K Kangawa, T Eto.   

Abstract

Accumulation of the intracellular cyclic AMP (cAMP) was measured in cultured endothelial cells of the human umbilical vein following the incubation with adrenomedullin, a newly discovered hypotensive peptide, to determine the presence of specific receptors for adrenomedullin. Adrenomedullin increased the intracellular cAMP in a dose-dependent fashion in the endothelial cells, and the EC50 value was as low as 10(-9) M. Calcitonin gene-related peptide (CGRP) that has a homology to adrenomedullin in its amino-acid sequence also increased the intracellular cAMP with an EC50 value greater than 10(-7) M. The effect of CGRP was attenuated in the presence of CGRP-(8-37), a CGRP receptor antagonist. However, CGRP-(8-37) had no effect on the cAMP accumulation by adrenomedullin. These findings indicate that the cultured endothelial cells of human umbilical vein possess specific adrenomedullin receptors coupled with the adenylate cyclase activity that may have little affinity with CGRP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621913     DOI: 10.1016/0922-4106(95)90117-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

Review 1.  Novel neurohumoral factors in congestive heart failure: adrenomedullin.

Authors:  J G Lainchbury
Journal:  Curr Cardiol Rep       Date:  2001-05       Impact factor: 2.931

2.  Adrenomedullin suppresses fMLP-induced upregulation of CD11b of human neutrophils.

Authors:  Y Saito; C Nakagawa; H Uchida; F Sasaki; H Sakakibara
Journal:  Inflammation       Date:  2001-06       Impact factor: 4.092

3.  Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP).

Authors:  I B Wilkinson; C M McEniery; K H Bongaerts; H MacCallum; D J Webb; J R Cockcroft
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

Review 4.  Adrenomedullin and cardiovascular diseases.

Authors:  Hoi Kin Wong; Tommy Tsang Cheung; Bernard M Y Cheung
Journal:  JRSM Cardiovasc Dis       Date:  2012-08-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.